ETF Inflow Update: PRF, UNH, RTX, BMY
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 23 2025
0mins
Source: NASDAQ.COM
52-Week Range and Current Price: PRF's share price has a 52-week low of $34.98 and a high of $45.40, with the last trade recorded at $45.31, indicating a stable position near its high.
Understanding ETFs: Exchange traded funds (ETFs) function like stocks, trading in "units" that can be created or destroyed based on investor demand, affecting the underlying assets held within the ETFs.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 285.170
Low
330.00
Averages
397.82
High
444.00
Current: 285.170
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health offers comprehensive and patient-centered care, addressing the physical, mental, social, and financial well-being. Optum Health delivers primary, specialty and surgical care; helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Bio-Techne and UnitedHealth Options Trading Activity Surges
- Bio-Techne Options Volume: Bio-Techne Corp (Ticker: TECH) has seen an options trading volume of 15,116 contracts today, equating to approximately 1.5 million shares, which represents a significant 62.4% of its average daily trading volume over the past month of 2.4 million shares.
- High Volume Contracts: Notably, the $60 strike call option for TECH has recorded a high volume of 5,055 contracts traded today, representing around 505,500 underlying shares, indicating strong market interest at this price level.
- UnitedHealth Options Activity: UnitedHealth Group Inc (Ticker: UNH) has reported an options trading volume of 39,170 contracts today, translating to approximately 3.9 million shares, which is about 47.5% of its average daily trading volume over the past month of 8.3 million shares, reflecting investor focus on its future performance.
- Key Contract Insights: The $300 strike call option for UNH has seen a trading volume of 2,172 contracts today, representing approximately 217,200 shares, suggesting bullish expectations in the market, potentially linked to anticipated future earnings performance.
See More
Centene Ranks as the Lowest Performing Stock in the S&P 500 Today: Here's the Reason.
- Stock Performance: Centene's stock has underperformed compared to the broader market this year, reflecting challenges faced by health insurers and managed-care companies.
- Regulatory Concerns: The company is navigating a changing regulatory environment, which has raised concerns among investors.
- Business Update Impact: A recent business update from Centene has heightened investor anxiety regarding the company's future prospects.
- Market Context: The struggles of Centene are indicative of broader issues within the health insurance sector amid evolving regulations.
See More
Analysis of XLV ETF's 52-Week Price Fluctuations
- Price Range Analysis: The XLV ETF has a 52-week low of $127.35 and a high of $160.59, with the last trade at $153.55, indicating stability and potential investment appeal in the current market.
- Technical Analysis Tool: Comparing the current share price to the 200-day moving average provides investors with valuable insights for technical analysis, aiding in market trend assessment and timing of investments.
- ETF Trading Mechanism: ETFs trade like stocks, where investors buy and sell 'units' that can be created or destroyed based on demand, impacting liquidity and market performance.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding helps identify ETFs experiencing significant inflows or outflows, allowing investors to capitalize on market dynamics and opportunities.
See More
Congressional Investigation Reveals Medicare Overpayment Issues
- Medicare Overpayment Investigation: The Joint Economic Committee's investigation revealed that alleged overpayments to Medicare Advantage plans resulted in a $13.4 billion increase in Medicare Part B premiums last year, primarily impacting seniors, highlighting potential financial pressures within the Medicare system.
- Premium Hike Impact: The investigation found that the average Medicare premium for American seniors rose by approximately 10%, equating to over $200 annually, directly affecting beneficiaries of both Medicare Advantage and standard Medicare, indicating a pressing need for policy adjustments.
- Insurer Rebuttal: America's Health Insurance Plans (AHIP), representing health insurers, denied the investigation's findings, claiming they were based on “fundamentally flawed data and methodology,” illustrating the industry's strong opposition to policy changes and potential conflicts of interest.
- Market Participant Overview: UnitedHealth (UNH) stands as the largest player in the Medicare Advantage market, followed by Humana (HUM) and others, underscoring the significant role and influence of major insurers in the evolving landscape of Medicare policy.
See More
U.S. Payrolls Unexpectedly Decline by 92,000 in February
- Weak Job Market: The U.S. nonfarm payrolls unexpectedly fell by 92,000 in February, significantly below the forecast of 50,000 and down from the revised January total of 126,000, indicating ongoing economic pressure from severe winter weather and a strike in the healthcare sector.
- Rising Unemployment Rate: The unemployment rate increased to 4.4%, reflecting job losses across key sectors, although a broader measure of unemployment, which includes discouraged workers and part-time workers for economic reasons, decreased to 7.9%, suggesting some resilience in the labor market.
- Wage Growth Exceeds Expectations: Despite the weak job data, average hourly earnings rose by 0.4% for the month and 3.8% year-over-year, both exceeding forecasts by 0.1 percentage points, indicating persistent labor cost pressures that could influence future monetary policy decisions.
- Significant Industry Impact: The healthcare sector lost 28,000 jobs due to the Kaiser Permanente strike, while information services and manufacturing saw declines of 11,000 and 12,000 jobs respectively, highlighting structural challenges within industries that may lead policymakers to adopt a more cautious approach in response to economic slowdown.
See More
Analysis of Current U.S. Labor Market Conditions
- Job Growth Expectations: February's nonfarm payrolls are projected to increase by approximately 60,000, down from 130,000 in January, indicating moderate growth in the labor market, though it fails to inspire strong economic confidence.
- Unemployment Rate Increase: The unemployment rate is expected to rise to 4.4% from 4.3% last month, reflecting signs of weakening consumer spending that could negatively impact economic growth.
- Weakening Consumer Spending: Real personal consumption expenditures have slowed to a year-over-year growth rate of 1.7%, about half of the long-term average, indicating a decline in consumer confidence that may affect future economic activity.
- Industry Dynamics Observation: While job growth in healthcare and social services continues, layoffs in the tech sector raise concerns, particularly regarding job shifts related to artificial intelligence, which may impact the overall structure of the labor market.
See More
Bio-Techne and UnitedHealth Options Trading Activity Surges
- Bio-Techne Options Volume: Bio-Techne Corp (Ticker: TECH) has seen an options trading volume of 15,116 contracts today, equating to approximately 1.5 million shares, which represents a significant 62.4% of its average daily trading volume over the past month of 2.4 million shares.
- High Volume Contracts: Notably, the $60 strike call option for TECH has recorded a high volume of 5,055 contracts traded today, representing around 505,500 underlying shares, indicating strong market interest at this price level.
- UnitedHealth Options Activity: UnitedHealth Group Inc (Ticker: UNH) has reported an options trading volume of 39,170 contracts today, translating to approximately 3.9 million shares, which is about 47.5% of its average daily trading volume over the past month of 8.3 million shares, reflecting investor focus on its future performance.
- Key Contract Insights: The $300 strike call option for UNH has seen a trading volume of 2,172 contracts today, representing approximately 217,200 shares, suggesting bullish expectations in the market, potentially linked to anticipated future earnings performance.
See More
Centene Ranks as the Lowest Performing Stock in the S&P 500 Today: Here's the Reason.
- Stock Performance: Centene's stock has underperformed compared to the broader market this year, reflecting challenges faced by health insurers and managed-care companies.
- Regulatory Concerns: The company is navigating a changing regulatory environment, which has raised concerns among investors.
- Business Update Impact: A recent business update from Centene has heightened investor anxiety regarding the company's future prospects.
- Market Context: The struggles of Centene are indicative of broader issues within the health insurance sector amid evolving regulations.
See More
Analysis of XLV ETF's 52-Week Price Fluctuations
- Price Range Analysis: The XLV ETF has a 52-week low of $127.35 and a high of $160.59, with the last trade at $153.55, indicating stability and potential investment appeal in the current market.
- Technical Analysis Tool: Comparing the current share price to the 200-day moving average provides investors with valuable insights for technical analysis, aiding in market trend assessment and timing of investments.
- ETF Trading Mechanism: ETFs trade like stocks, where investors buy and sell 'units' that can be created or destroyed based on demand, impacting liquidity and market performance.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding helps identify ETFs experiencing significant inflows or outflows, allowing investors to capitalize on market dynamics and opportunities.
See More
Congressional Investigation Reveals Medicare Overpayment Issues
- Medicare Overpayment Investigation: The Joint Economic Committee's investigation revealed that alleged overpayments to Medicare Advantage plans resulted in a $13.4 billion increase in Medicare Part B premiums last year, primarily impacting seniors, highlighting potential financial pressures within the Medicare system.
- Premium Hike Impact: The investigation found that the average Medicare premium for American seniors rose by approximately 10%, equating to over $200 annually, directly affecting beneficiaries of both Medicare Advantage and standard Medicare, indicating a pressing need for policy adjustments.
- Insurer Rebuttal: America's Health Insurance Plans (AHIP), representing health insurers, denied the investigation's findings, claiming they were based on “fundamentally flawed data and methodology,” illustrating the industry's strong opposition to policy changes and potential conflicts of interest.
- Market Participant Overview: UnitedHealth (UNH) stands as the largest player in the Medicare Advantage market, followed by Humana (HUM) and others, underscoring the significant role and influence of major insurers in the evolving landscape of Medicare policy.
See More
U.S. Payrolls Unexpectedly Decline by 92,000 in February
- Weak Job Market: The U.S. nonfarm payrolls unexpectedly fell by 92,000 in February, significantly below the forecast of 50,000 and down from the revised January total of 126,000, indicating ongoing economic pressure from severe winter weather and a strike in the healthcare sector.
- Rising Unemployment Rate: The unemployment rate increased to 4.4%, reflecting job losses across key sectors, although a broader measure of unemployment, which includes discouraged workers and part-time workers for economic reasons, decreased to 7.9%, suggesting some resilience in the labor market.
- Wage Growth Exceeds Expectations: Despite the weak job data, average hourly earnings rose by 0.4% for the month and 3.8% year-over-year, both exceeding forecasts by 0.1 percentage points, indicating persistent labor cost pressures that could influence future monetary policy decisions.
- Significant Industry Impact: The healthcare sector lost 28,000 jobs due to the Kaiser Permanente strike, while information services and manufacturing saw declines of 11,000 and 12,000 jobs respectively, highlighting structural challenges within industries that may lead policymakers to adopt a more cautious approach in response to economic slowdown.
See More
Analysis of Current U.S. Labor Market Conditions
- Job Growth Expectations: February's nonfarm payrolls are projected to increase by approximately 60,000, down from 130,000 in January, indicating moderate growth in the labor market, though it fails to inspire strong economic confidence.
- Unemployment Rate Increase: The unemployment rate is expected to rise to 4.4% from 4.3% last month, reflecting signs of weakening consumer spending that could negatively impact economic growth.
- Weakening Consumer Spending: Real personal consumption expenditures have slowed to a year-over-year growth rate of 1.7%, about half of the long-term average, indicating a decline in consumer confidence that may affect future economic activity.
- Industry Dynamics Observation: While job growth in healthcare and social services continues, layoffs in the tech sector raise concerns, particularly regarding job shifts related to artificial intelligence, which may impact the overall structure of the labor market.
See More
